Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ALLR Allarity Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: ALLR
Price (delayed)
$1.04
Market cap
$15.68M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.58
Enterprise value
-$10.66M
Highlights
Allarity Therapeutics's EPS has surged by 100% YoY and by 90% QoQ
ALLR's equity has soared by 58% from the previous quarter
Allarity Therapeutics's net income has shrunk by 89% YoY but it has increased by 4.5% QoQ
Key stats
What are the main financial stats of ALLR
Market
Valuations
Earnings
Shares outstanding
15.08M
Market cap
$15.68M
Enterprise value
-$10.66M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.95
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$26.04M
Net income
-$23.4M
EBIT
-$23.17M
EBITDA
-$23.16M
Free cash flow
-$18.55M
Per share
Balance sheet
Liquidity
EPS
-$1.58
EPS diluted
-$1.58
Free cash flow per share
-$1.66
Book value per share
$1.1
Revenue per share
$0
TBVPS
$2.67
Total assets
$29.73M
Total liabilities
$11.06M
Debt
$1.36M
Equity
$18.67M
Working capital
$18.36M
Debt to equity
0.07
Current ratio
2.66
Quick ratio
2.5
Net debt/EBITDA
1.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-92.7%
Return on equity
-151.7%
Return on invested capital
N/A
Return on capital employed
-124.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALLR stock price
How has the Allarity Therapeutics stock price performed over time
Intraday
1.96%
1 week
-2.8%
1 month
42.23%
1 year
-95.64%
YTD
-11.11%
QTD
11%
Financial performance
How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.04M
Net income
-$23.4M
Gross margin
N/A
Net margin
N/A
Allarity Therapeutics's net income has shrunk by 89% YoY but it has increased by 4.5% QoQ
ALLR's operating income is down by 47% year-on-year but it is up by 4.4% since the previous quarter
Price vs fundamentals
How does ALLR's price correlate with its fundamentals
Growth
What is Allarity Therapeutics's growth rate over time
Valuation
What is Allarity Therapeutics stock price valuation
P/E
N/A
P/B
0.95
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Allarity Therapeutics's EPS has surged by 100% YoY and by 90% QoQ
ALLR's P/B is 138% above its last 4 quarters average of 0.4
ALLR's equity has soared by 58% from the previous quarter
Efficiency
How efficient is Allarity Therapeutics business performance
Allarity Therapeutics's ROA has increased by 43% YoY and by 21% from the previous quarter
ALLR's ROE is up by 42% QoQ
Dividends
What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALLR.
Financial health
How did Allarity Therapeutics financials performed over time
ALLR's total assets is 169% more than its total liabilities
ALLR's total assets has soared by 148% YoY and by 31% from the previous quarter
Allarity Therapeutics's total liabilities has decreased by 40% YoY but it has increased by 2% from the previous quarter
The company's debt is 93% lower than its equity
ALLR's debt to equity has surged by 117% year-on-year but it is down by 36% since the previous quarter
ALLR's equity has soared by 58% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.